Published in Curr Biol on September 11, 2012
Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer (2013) 2.56
Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature (2013) 2.53
Genome dynamics during experimental evolution. Nat Rev Genet (2013) 2.07
Whole genome, whole population sequencing reveals that loss of signaling networks is the major adaptive strategy in a constant environment. PLoS Genet (2013) 1.40
Molecular heterogeneity in glioblastoma: potential clinical implications. Front Oncol (2015) 1.06
Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med (2014) 0.90
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine. Trends Cancer (2016) 0.90
Clonal selection and therapy resistance in acute leukaemias: mathematical modelling explains different proliferation patterns at diagnosis and relapse. J R Soc Interface (2014) 0.86
Systems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence". Cancer Metastasis Rev (2013) 0.86
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications. Genome Med (2013) 0.84
First principles of Hamiltonian medicine. Philos Trans R Soc Lond B Biol Sci (2014) 0.83
Population dynamics of metastable growth-rate phenotypes. PLoS One (2013) 0.81
The effect of population bottlenecks on mutation rate evolution in asexual populations. J Evol Biol (2013) 0.81
A Genetic Incompatibility Accelerates Adaptation in Yeast. PLoS Genet (2015) 0.79
Evolutionary perspective of cancer: myth, metaphors, and reality. Evol Appl (2015) 0.79
Protecting the normal in order to better kill the cancer. Cancer Med (2015) 0.78
Spatial Moran models, II: cancer initiation in spatially structured tissue. J Math Biol (2015) 0.78
The shock of being united and symphiliosis. Another lesson from plants? Cell Cycle (2014) 0.77
Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach. BMC Syst Biol (2016) 0.76
Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors. J Cancer (2016) 0.76
Biochemistry and physiology within the framework of the extended synthesis of evolutionary biology. Biol Direct (2016) 0.75
Kinesin-5 Contributes to Spindle-length Scaling in the Evolution of Cancer toward Metastasis. Sci Rep (2016) 0.75
Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing. BMC Med Genomics (2017) 0.75
Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization. Hum Genomics (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer (2002) 34.99
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Adaptive protein evolution at the Adh locus in Drosophila. Nature (1991) 31.65
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
The clonal evolution of tumor cell populations. Science (1976) 24.39
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Cancer genes and the pathways they control. Nat Med (2004) 24.22
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20
Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med (2008) 13.54
Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature (2009) 13.45
Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften (1971) 13.09
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
THE RELATION OF RECOMBINATION TO MUTATIONAL ADVANCE. Mutat Res (1964) 11.15
Clonal evolution in cancer. Nature (2012) 11.07
Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat Rev Genet (2003) 10.52
Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med (2012) 10.20
Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75
The fate of competing beneficial mutations in an asexual population. Genetica (1998) 9.60
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature (2002) 9.07
Darwinian evolution can follow only very few mutational paths to fitter proteins. Science (2006) 9.07
The origin of mutants. Nature (1988) 8.92
Evolution of high mutation rates in experimental populations of E. coli. Nature (1997) 8.68
Adaptive radiation in a heterogeneous environment. Nature (1998) 8.44
Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations. Proc Natl Acad Sci U S A (1994) 8.16
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell (2010) 7.78
Asymmetric and symmetric stem-cell divisions in development and cancer. Nature (2006) 7.32
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A (2008) 7.22
The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle. Naturwissenschaften (1977) 7.19
Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A (2010) 7.07
Clonal architecture of secondary acute myeloid leukemia. N Engl J Med (2012) 6.71
Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet (2006) 6.71
Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature (2011) 6.39
Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16
Role of mutator alleles in adaptive evolution. Nature (1997) 5.95
Oncogene addiction. Cancer Res (2008) 5.66
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell (2012) 5.62
The accumulation of deleterious genes in a population--Muller's Ratchet. Theor Popul Biol (1978) 5.51
The increasing complexity of the cancer stem cell paradigm. Science (2009) 5.45
Cancer stem cells: mirage or reality? Nat Med (2009) 5.20
Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell (2012) 5.16
Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2002) 4.97
Perspective: Sign epistasis and genetic constraint on evolutionary trajectories. Evolution (2005) 4.93
Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res (2006) 4.72
Exceptional convergent evolution in a virus. Genetics (1997) 4.69
The mutational meltdown in asexual populations. J Hered (1993) 4.65
Self-generated diversity produces "insurance effects" in biofilm communities. Proc Natl Acad Sci U S A (2004) 4.54
Negative epistasis between beneficial mutations in an evolving bacterial population. Science (2011) 4.47
Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A (2010) 4.47
Diminishing returns epistasis among beneficial mutations decelerates adaptation. Science (2011) 4.29
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest (2010) 4.22
Multiple mutations and cancer. Proc Natl Acad Sci U S A (2003) 4.21
The population genetics of dN/dS. PLoS Genet (2008) 3.88
Periodic selection in Escherichia coli. Proc Natl Acad Sci U S A (1951) 3.77
The speed of evolution and maintenance of variation in asexual populations. Curr Biol (2007) 3.74
Virus dynamics and drug therapy. Proc Natl Acad Sci U S A (1997) 3.63
The repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited environments in yeast. PLoS Genet (2008) 3.58
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.57
Proliferation of mutators in A cell population. J Bacteriol (1997) 3.55
The evolution of mutation rates: separating causes from consequences. Bioessays (2000) 3.48
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A (2001) 3.42
Tests of parallel molecular evolution in a long-term experiment with Escherichia coli. Proc Natl Acad Sci U S A (2006) 3.39
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
The molecular diversity of adaptive convergence. Science (2012) 3.27
Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell (2008) 3.26
Microbial evolution in a simple unstructured environment: genetic differentiation in Escherichia coli. Genetics (1994) 3.19
Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res (2010) 3.19
Frequency of fixation of adaptive mutations is higher in evolving diploid than haploid yeast populations. Nature (1983) 3.03
Drug resistance in cancer: principles of emergence and prevention. Proc Natl Acad Sci U S A (2005) 3.03
The solitary wave of asexual evolution. Proc Natl Acad Sci U S A (2003) 2.97
The mutation rate and cancer. Proc Natl Acad Sci U S A (1996) 2.73
Repeated evolution of an acetate-crossfeeding polymorphism in long-term populations of Escherichia coli. Mol Biol Evol (1998) 2.69
Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme. Nature (2011) 2.63
Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci U S A (2000) 2.61
Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria. Genetics (1999) 2.60
The speed of adaptation in large asexual populations. Genetics (2004) 2.59
Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol Evol (2011) 2.48
Social strife in the microbial world. Trends Microbiol (2003) 2.42
Relative fitness can decrease in evolving asexual populations of S. cerevisiae. Nature (2006) 2.40
Long-Term Experimental Evolution in Escherichia coli. VIII. Dynamics of a Balanced Polymorphism. Am Nat (2000) 2.29
Looking for Darwin in all the wrong places: the misguided quest for positive selection at the nucleotide sequence level. Heredity (Edinb) (2007) 2.26
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science (2011) 2.26
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci U S A (2011) 2.25
Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol (2004) 2.23
Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J Clin Invest (1970) 2.21
Pervasive cryptic epistasis in molecular evolution. PLoS Genet (2010) 2.19
Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res (2004) 2.15
Clonal evolution in cancer. Nature (2012) 11.07
Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33
Fitness effects of fixed beneficial mutations in microbial populations. Curr Biol (2002) 3.22
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol (2007) 3.00
Peto's Paradox: evolution's prescription for cancer prevention. Trends Ecol Evol (2011) 2.48
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23
Population genetic variation in gene expression is associated with phenotypic variation in Saccharomyces cerevisiae. Genome Biol (2004) 1.96
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res (Phila) (2010) 1.89
Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics (2002) 1.85
Allopatric divergence, secondary contact, and genetic isolation in wild yeast populations. Curr Biol (2007) 1.69
Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays (2014) 1.64
Beneficial mutations and the dynamics of adaptation in asexual populations. Philos Trans R Soc Lond B Biol Sci (2010) 1.60
Evaluating the impact of population bottlenecks in experimental evolution. Genetics (2002) 1.58
Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) (2008) 1.43
Complete genetic linkage can subvert natural selection. Proc Natl Acad Sci U S A (2007) 1.42
Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One (2011) 1.32
Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31
Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) (2011) 1.21
Animal cell differentiation patterns suppress somatic evolution. PLoS Comput Biol (2007) 1.19
Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res (2009) 1.17
Life history trade-offs in cancer evolution. Nat Rev Cancer (2013) 1.16
Solving the puzzle of metastasis: the evolution of cell migration in neoplasms. PLoS One (2011) 1.12
The fixation probability of a beneficial allele in a population dividing by binary fission. Genetica (2002) 1.09
Spontaneously arising mutL mutators in evolving Escherichia coli populations are the result of changes in repeat length. J Bacteriol (2003) 1.08
Sympatric natural Saccharomyces cerevisiae and S. paradoxus populations have different thermal growth profiles. FEMS Yeast Res (2004) 1.07
The role of genetic diversity in cancer. J Clin Invest (2010) 1.05
Modelling the evolution of genetic instability during tumour progression. Evol Appl (2012) 1.04
Competition between high- and higher-mutating strains of Escherichia coli. Biol Lett (2011) 1.04
Spatial structure increases the waiting time for cancer. New J Phys (2011) 1.02
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Cancer Epidemiol Biomarkers Prev (2006) 0.98
NSAIDs modulate clonal evolution in Barrett's esophagus. PLoS Genet (2013) 0.98
Identifying mutator phenotypes among fluoroquinolone-resistant strains of Streptococcus pneumoniae using fluctuation analysis. Antimicrob Agents Chemother (2007) 0.98
Mate choice assays and mating propensity differences in natural yeast populations. Biol Lett (2006) 0.98
Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc Natl Acad Sci U S A (2008) 0.97
New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management. Clin Cancer Res (2011) 0.96
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science. Biol Blood Marrow Transplant (2010) 0.95
Mutator dynamics in sexual and asexual experimental populations of yeast. BMC Evol Biol (2011) 0.94
Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res (Phila) (2011) 0.91
Deletion at fragile sites is a common and early event in Barrett's esophagus. Mol Cancer Res (2010) 0.89
Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev (2006) 0.87
Natural resistance to cancers: a Darwinian hypothesis to explain Peto's paradox. BMC Cancer (2012) 0.87
Sequence space coverage, entropy of genomes and the potential to detect non-human DNA in human samples. BMC Genomics (2008) 0.87
Luria-delbruck estimation of turnip mosaic virus mutation rate in vivo. J Virol (2012) 0.86
Natural selection promotes antigenic evolvability. PLoS Pathog (2013) 0.85
Heterochronic evolution reveals modular timing changes in budding yeast transcriptomes. Genome Biol (2010) 0.85
Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med (2010) 0.84
An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition. BMC Cancer (2011) 0.83
Contrasting dynamics of a mutator allele in asexual populations of differing size. Evolution (2012) 0.83
Distribution and sequence analysis of a novel Ty3-like element in natural Saccharomyces paradoxus isolates. Yeast (2003) 0.83
An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evol Appl (2012) 0.82
Genomic mutation rates that neutralize adaptive evolution and natural selection. J R Soc Interface (2013) 0.82
New models of neoplastic progression in Barrett's oesophagus. Biochem Soc Trans (2010) 0.80
Development and characterization of an organotypic model of Barrett's esophagus. J Cell Physiol (2012) 0.80
Real time forecasting of near-future evolution. J R Soc Interface (2012) 0.78
Polyploidy, aneuploidy and the evolution of cancer. Adv Exp Med Biol (2010) 0.78
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol (2005) 0.78
An investigation of error sources and their impact in estimating the time to the most recent ancestor of spatially and temporally distributed HIV sequences. Stat Med (2003) 0.75